Company & Sponsor Intelligence
Stalicla SA
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
autism
Indexed studies
NCT04273087Characterization of a Clinical Subpopulation With Autism Spectrum Disorder
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT04644003Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)
autism · United StatesPHASE1
autism · United StatesPHASE1
NCT04600882Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder
autism · United StatesWITHDRAWN
autism · United StatesWITHDRAWN
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →